Total syntheses of ningalin A, lamellarin O, lukianol A, and permethyl storniamide A utilizing heterocyclic azadiene Diels - Alder reactions

Article abstract of DOI:10.1021/ja982078+

Concise, efficient total syntheses of ningalin A (1), lamellarin O (2), lukianol A (3), and permethyl storniamide A (5) are detailed on the basis of a common heterocyclic azadiene Diels-Alder strategy (1,2,4,5-tetrazine → 1,2-diazine → pyrrole) ideally suited for construction of the densely functionalized pyrrole cores found in the three classes of marine natural products. Examination of the natural products and a number of synthetic intermediates revealed that some including lamellarin O (2) and lukianol A (3) exhibit modest cytotoxic activity against both wild-type and multidrug- resistant tumor cell lines. Fundamentally more important, a new class of agents including permethyl storniamide A (5) and its precursor 30, which lack inherent cytotoxic activity, are disclosed which reverse the multidrug- resistant (MDR) phenotype, resensitizing a human colon cancer cell line (HCT116/VM46) to vinblastine and doxorubicin at lower doses than the prototypical agent verapamil.

Full text of DOI:10.1021/ja982078+

54
J. Am. Chem. Soc. 1999, 121, 54-62
Total Syntheses of Ningalin A, Lamellarin O, Lukianol A, and
Permethyl Storniamide A Utilizing Heterocyclic Azadiene
Diels-Alder Reactions
Dale L. Boger,* Christopher W. Boyce, Marc A. Labroli, Clark A. Sehon, and Qing Jin
Contribution from the Department of Chemistry and The Skaggs Institute for Chemical Biology,
The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037
ReceiVed June 15, 1998
Abstract: Concise, efficient total syntheses of ningalin A (1), lamellarin O (2), lukianol A (3), and permethyl
storniamide A (5) are detailed on the basis of a common heterocyclic azadiene Diels-Alder strategy (1,2,4,5-
tetrazine f 1,2-diazine f pyrrole) ideally suited for construction of the densely functionalized pyrrole cores
found in the three classes of marine natural products. Examination of the natural products and a number of
synthetic intermediates revealed that some including lamellarin O (2) and lukianol A (3) exhibit modest cytotoxic
activity against both wild-type and multidrug-resistant tumor cell lines. Fundamentally more important, a new
class of agents including permethyl storniamide A (5) and its precursor 30, which lack inherent cytotoxic
activity, are disclosed which reverse the multidrug-resistant (MDR) phenotype, resensitizing a human colon
cancer cell line (HCT116/VM46) to vinblastine and doxorubicin at lower doses than the prototypical agent
verapamil.
The recently identified marine natural products ningalin A
P-gp-mediated drug efflux.8 Thus, they constitute a new class
of antitumor agents active against resistant cell lines, and they
additionally reverse MDR at noncytotoxic concentrations even
more effectively than verapamil, resensitizing the resistant
malignant cells to front-line therapeutics.
Storniamide A (4) is a member of a new class of secondary
metabolites isolated in 1996 from a Patagonian sponge off the
coast of Argentina.9 The crude ethanolic extract of the burrowing
yellow sponge Cliona sp. showed antibiotic activity against
Gram-positive bacteria. Purification of the individual constitu-
ents was accomplished by bioassay-guided fractionation to
reveal four members of this new family of alkaloids, storniamide
A-D. Characterization showed that each differs only in the
oxygenation pattern within the peripheral aromatic rings, with
4 being a prototypical member.
Herein we describe total syntheses of ningalin A, lamellarin
O, lukianol A, and permethyl storniamide A (5), enlisting a
common strategy applicable to related natural products and
synthetic analogues (Figure 1). The concise, nonobvious ap-
proach employs a heteroaromatic azadiene Diels-Alder reac-
tion10 to assemble the substituents onto a six-membered 1,2-
diazine core which is followed by a reductive ring contraction
reaction11-13 to provide the corresponding pyrrole, a five-
(1), lamellarin O (2), lukianol A (3), and storniamide A (4) each
possess a common 3,4-diaryl-substituted pyrrole nucleus bearing
2- or 2,5-carboxylates. Ningalin A (1) is the simplest member
of a newly described family of marine natural products isolated
by Fenical (1997) from an ascidian of the genus Didemnum
collected in western Australia near Ningaloo Reef which appear
to be derived from condensation of 3,4-dihydroxyphenylalanine
(DOPA).1 Consequently, 1 and the related ningalins B-D are
the newest members of a family of DOPA-derived o-catechol
metabolites that include the tunichromes.
Lamellarin O (2)2 is a prototypical member of a rapidly
growing class of marine natural products3-6 which was first
isolated from the southern Australian marine sponge Dendrilla
cactos by Capon (1994), and important members of this class
have been disclosed by Faulkner, Fenical, and Bowden. It has
been reported that biological activity could not be obtained for
natural lamellarin O due to its instability and limited avail-
ability.2 Lukianol A (3), a structurally related compound, was
discovered in an unidentified pacific tunicate by Scheuer (1992)7
and shown to exhibit cytotoxic activity against a cell line derived
from human epidermatoid carcinoma (KB). More recent inves-
tigations of related lamellarins have confirmed their cytotoxic
activity, revealed equally effective cytotoxic activity against
multidrug-resistant (MDR) cell lines, and demonstrated that even
at noncytotoxic concentrations they reverse MDR by inhibiting
(1) Kang, H.; Fenical, W. J. Org. Chem. 1997, 62, 3254.
(2) Urban, S.; Butler, M. S.; Capon, R. J. Aust. J. Chem. 1994, 47, 1919.
(3) Anderson, R. J.; Faulkner, D. J.; Cun-heng, H.; Van Duyne, G. D.;
Clardy, J. J. Am. Chem. Soc. 1985, 107, 5492. Reddy, M. V. R.; Faulkner,
D. J.; Venkateswarlu, Y.; Rao, M. R. Tetrahedron 1997, 53, 3457.
(4) Lindquist, N.; Fenical, W.; Van Duyne, G. D.; Clardy, J. J. Org.
Chem. 1988, 53, 4570.
(5) Urban, S.; Capon, R. J. Aust. J. Chem. 1996, 49, 711.
(6) Carroll, A. R.; Bowden, B. F.; Coll, J. C. Aust. J. Chem. 1993, 46,
489.
(8) Quesada, A. R.; Gravalos, M. D. G.; Puentes, J. L. F. Br. J. Cancer
1996, 74, 677.
(9) Palermo, J. A.; Brasco, M. F. R.; Seldes, A. M. Tetrahedron 1996,
52, 2727.
(10) Boger, D. L. Chemtracts: Org. Chem. 1996, 9, 149. Boger, D. L.
Bull. Chim. Soc., Belg. 1990, 99, 599. Boger, D. L.; Patel, M. In Progress
in Heterocyclic Chemistry; Suschitzky, H., Scriven, E. F. V., Eds.;
Pergamon: Oxford, 1989; Vol. 1, p 30. Boger, D. L.; Weinreb, S. M. Hetero
Diels-Alder Methodology in Organic Synthesis; Academic: San Diego,
1987. Boger, D. L. Chem. ReV. 1986, 86, 781. Boger, D. L. Tetrahedron
1983, 39, 2869.
(11) Boger, D. L.; Coleman, R. S.; Panek, J. S.; Yohannes, D. J. Org.
Chem. 1984, 49, 4405.
(7) Yoshida, W. Y.; Lee, K. K.; Carroll, A. R.; Scheuer, P. J. HelV. Chim.
Acta 1992, 75, 1721.
(12) Boger, D. L.; Patel, M. J. Org. Chem. 1988, 53, 1405. Boger, D.
L.; Baldino, C. M. J. Am. Chem. Soc. 1993, 115, 11418.
10.1021/ja982078+ CCC: $18.00 © 1999 American Chemical Society
Published on Web 12/19/1998

Heterocyclic Azadiene Diels-Alder Reactions
J. Am. Chem. Soc., Vol. 121, No. 1, 1999 55
Scheme 2
Figure 1.
4,5-dimethoxy-2-(methoxymethoxy)benzene (7)16 with bis-
(tributylstannyl)acetylene17 (Pd(PPh3)4, 79%), Scheme 2. The
first of the two key conversions in the synthesis, the Diels-
Alder reaction of the electron-deficient 1,2,4,5-tetrazine 613 with
the electron-rich acetylene 8, was carried out in toluene at 110
°C to afford the desired 1,2-diazine 9 in excellent yield (87%)
as a 2.4:1 mixture of atropisomers. The relative effectiveness
of the Diels-Alder reaction of the alkyne 8 in comparison with
unactivated alkynes14 may be attributed to the electron-donating
properties of the dienophile aryl alkoxy groups. Subsequent
reductive ring contraction of 1,2-diazine 9 effected by treatment
with zinc (HOAc, 63%) smoothly afforded the desired pyrrole
10. Deprotection of the MOM ethers through treatment of 10
with 3 M HCl-EtOAc afforded a mixture of the corresponding
diphenol and the monolactone 11, which completely converted
to the monolactone 11 (94%) upon SiO2 chromatography.
Because of the steric congestion and rotational barrier of the
two ortho aryl rings, more forcing conditions (DBU, 100%) were
required for formation of the second lactone, providing tetra-
methyl ningalin A (12). Exhaustive demethylation with BBr3
(96%) completed the first total synthesis of ningalin (1, 49%
overall yield) and provided material that was identical in all
respects (1H NMR, 13C NMR, IR, MS)18 with authentic
material.1
Scheme 1
membered heteroaromatic system not commonly assembled by
a [4 + 2] cycloaddition reaction (Scheme 1).
Importantly, the oxygenation pattern found in the diaryl
groups would be expected to increase the nucleophilic character
of the corresponding acetylene and improve what is a typically
poor reactivity of the alkynes toward 6.14 This approach lends
itself to the synthesis of the natural products and a range of
analogues by use of alternative acetylenes or by functionalization
of the diesters for further elaboration of the common central
core with the potential for desymmetrization. As such, its
implementation detailed herein complements the limited syn-
thetic efforts disclosed to date on the three classes of marine
natural products.15
Total Synthesis of Lamellarin O and Lukianol A. The
acetylenic precursor common to lamellarin O and lukianol A
Total Synthesis of Ningalin A. The requisite diphenylacet-
ylene 8 was prepared by a double Stille coupling of 1-bromo-
(13) Boger, D. L.; Panek, J. S.; Coleman, R. S.; Sauer, J.; Huber, F. X.
J. Org. Chem. 1985, 50, 5377. Boger, D. L.; Panek, J. S.; Patel, M. Org.
Synth. 1991, 70, 79.
(14) Sauer, J.; Mielert, A.; Lang, D.; Peter, D. Chem. Ber. 1965, 98,
1435.
(16) Donnelly, D. M. X.; Finet, J.-P.; Rattigan, B. A. J. Chem. Soc.,
Perkin Trans. 1 1995, 1679. Prepared by Baeyer-Villiger oxidation of
commercially available 6-bromoveratraldehyde (mCPBA, 97%), subsequent
formate methanolysis (catalytic NaOCH3, 72%), and protection as the
methoxymethyl ether (MOMCl, NaH, 77%).
(15) Lukianol A and lamellarin O dimethyl ether: Fu¨rstner, A.; Weintritt,
H.; Hupperts, A. J. Org. Chem. 1995, 60, 6637. Lamellarin O and Q and
lukianol A: Banwell, M. G.; Flynn, B. L.; Hamel, E.; Hockless, D. C. R.
Chem. Commun. 1997, 207. Lamellarin K: Banwell, M.; Flynn, B.;
Hockless, D. Chem. Commun. 1997, 2259. Lamellarin D and H: Ishibashi,
F.; Miyazaki, Y.; Iwao, M. Tetrahedron 1997, 53, 5951. Lamellarin G
trimethyl ether: Heim, A.; Terpin, A.; Steglich, W. Angew. Chem., Int.
Ed. Engl. 1997, 36, 155.
(17) Cummins, C. H. Tetrahedron Lett. 1994, 35, 857.
(18) The reported 13C NMR (DMSO-d6, 50 MHz)1 for 1 does not list a
broadened signal observed at ca. δ 123 (Supporting Information spectrum
supplied in ref 1) and assigns two distinct carbons (C2 and C9) to a single
resonance (δ 110.3). The 13C NMR (DMSO, 100 MHz) of our synthetic
sample of 1 was identical in all respects except this additional broadened
singlet was observed as a sharp singlet at δ 122.9, which we tentatively
assign as C2.

56 J. Am. Chem. Soc., Vol. 121, No. 1, 1999
Boger et al.
Scheme 3
Scheme 4
was prepared by a palladium(0)-catalyzed cross-coupling of the
terminal acetylene 1319 and 1419 (0.03 equiv of Pd, 0.06 equiv
of CuI, Et3N, 75%) in which slow addition of the acetylene
was necessary to suppress formation of the coupled diacetylene
(Scheme 3). Initial Stille coupling attempts using bis(tributyl-
stannyl)acetylene17 and the aryl iodide 14 led predominately to
the symmetrical coupled diacetylene.20 Acetylene 15 was
allowed to react with 1,2,4,5-tetrazine 6 to give the desired 1,2-
diazine 16 in excellent yield (toluene, 100 °C, 85%). Zinc
reductive ring contraction (HOAc, 72%) followed by N-
alkylation of the resulting pyrrole 17 with the commercially
available 2-bromo-4′-methoxyacetophenone (18) gave the pen-
tasubstituted pyrrole 19 (100%). The symmetrical diester 19
was subjected to a gratifyingly selective hydrolysis with LiOH
(1.3 equiv, 76%) to provide the monoacid 20. We attribute this
selective hydrolysis to phenacyl enolate generation under the
reaction conditions followed by enol lactone closure onto either
of the dimethyl esters and subsequent preferential hydrolytic
cleavage of the enol lactone. The resulting acid 20 was treated
with trifluoroacetic acid (5 equiv, CH2Cl2, 40 °C, 5 h, 97%) to
promote decarboxylation and afford the appropriately substituted
and functionalized pyrrole core 21 found in both lamellarin O
and lukianol A. This key intermediate could be quantitatively
converted to lamellarin O (2) by catalytic hydrogenation or,
more simply, by conducting a TFA treatment of 20 or 21 at
more elevated temperatures (neat TFA, 70 °C, 3 h, 84%).
Analogous to the efforts of Fu¨rstner,15 pyrrole 21 was saponified
with LiOH (98%), and the resulting carboxylic acid 22 was
efficiently converted to the enol lactone 23 (NaOAc, Ac2O,
72%). Treatment of 23 with BBr3 removed both the benzyl
ethers and methyl ether in excellent yield (72%) to afford
1
lukianol A (3). The H NMR, 13C NMR, IR, MS, and mp of
synthetic 2 (45% overall yield) and 3 (23% overall yield) were
identical in all respects with those reported for authentic or
natural material.
Total Synthesis of Permethyl Storniamide A. The prepara-
tion of the acetylenic dienophile for the storniamide A synthesis,
1,2-bis(3,4,5-trimethoxyphenyl)acetylene (26), was accom-
plished by Pd(0)-catalyzed coupling of the terminal alkyne 2421
with the aryl triflate 2521 (CuI, Et3N, 90%), Scheme 4. Initial
attempts to couple the terminal acetylene 24 and the aryl triflate
25 under reported conditions22 (catalytic PdCl2(PPh3)2, catalytic
CuI, Bu4NI, 25 and 70 °C) gave an approximately 1:1 mixture
(19) Biftu, T.; Schneiders, G. E.; Stevenson, R. J. Chem. Res., Synop.
1982, 270. Orito, K.; Hatakeyama, T.; Takeo, M.; Suginome, H. Synthesis
1995, 1273.
(20) Data for 1,4-bis(4-benzyloxyphenyl)-1,3-butadiyne: 1H NMR (CDCl3,
250 MHz) δ 7.44 (d, J ) 8.3 Hz, 4H), 7.37-7.33 (m, 10H), 6.94 (d, J )
8.7 Hz, 4H), 5.08 (s, 4H); 13C NMR (CDCl3, 100 MHz) δ 159.4, 136.4,
134.1, 128.7, 128.2, 127.5, 115.0, 114.2, 81.2, 73.0, 70.0; FABHRMS (NBA/
NaI) m/z 415.1684 (M + H+, C30H22O2 requires 415.1698).
(21) Fu¨rstner, A.; Nikolakis, K. Liebigs Ann. 1996, 2107.
(22) Powell, N. A.; Rychnovsky, S. D. Tetrahedron Lett. 1996, 37, 7901.

Heterocyclic Azadiene Diels-Alder Reactions
J. Am. Chem. Soc., Vol. 121, No. 1, 1999 57
Table 1. In Vitro Cytotoxic Activity
of the desired cross-coupled product 26 and the undesired
diacetylene dimer. Modifying the procedure to include slow
addition of alkyne 24 to the reaction mixture at 70 °C gave
only the desired diphenylacetylene 26 in superb conversion
(90%), in which elevating the temperature promotes the slow
Pd(0) oxidative addition of the triflate and limiting the relative
concentration of 24 avoids the undesired competitive self-
coupling reaction. The first of the two key conversions involving
the Diels-Alder reaction of the electron-deficient 1,2,4,5-
tetrazine 6 with the electron-rich acetylene 26 proceeded in
toluene to give the desired 1,2-diazine in excellent yield (110
°C, 90%). The unusual facility with which this [4 + 2]
cycloaddition reaction occurs may be attributed to the six
methoxy groups donating electron density into the dienophile.
Subsequent zinc reductive ring contraction (HOAc, 69%) of 27
afforded the pyrrole 28 and the core structure found in the
natural product. N-Alkylation with the phenethyl bromide 2923
and subsequent saponification with KOH in 4:2:1 dioxane-
CH3OH-H2O gave the pentasubstituted pyrrole diacid 31 and
set the stage for introduction of the sensitive enamides. The
diacid 31 was coupled with amine 3224 (PyBrOP)25 to provide
the diamide 33, and the overall conversions of 28 to 33 were
sufficiently effective that the three steps could be conducted
without intermediate purification and in 99% overall yield.
Thioether oxidation (NaIO4) with subsequent thermal sulfoxide
elimination gave a separable 2:1 mixture of the E,E- and E,Z-
dienamides 5 in 76% for the two steps and in 47% overall
yield.26 Attempts to isomerize the undesired E,Z-isomer with
light and mild acid resulted in recovered starting material,
decomposition, or undesired side reactions. However, treatment
of the E,Z-isomer with I2 (0.5 equiv, CHCl3, 25 °C) under room
lighting gave an approximately 2:1 mixture of E,E- and E,Z-
isomers, and a similar treatment of the E,E-isomer gave the same
thermodynamic 2:1 mixture.
Cytotoxic Activity and Reversal of Multidrug Resistance.
A number of compounds in these three classes of natural
products have been shown to exhibit cytotoxic activity8 includ-
ing lukianol A (3), which is reported to be active against a cell
line derived from human epidermatoid carcinoma (KB).7
However, the biological evaluation of most members has not
been fully explored, and some, including lamellarin O (2), were
sufficiently unstable and isolated in quantities that precluded
their examination.2 Consequently, the natural products and a
number of structurally related synthetic intermediates were tested
in a L1210 cytotoxic assay, and the results are summarized in
Table 1. Both lamellarin O (2) and lukianol A (3) were found
to be equally active against L1210 while 3 was 15-20 times
less active against HTC116, ningalin A (1) was found to be
weakly active, and a number of the synthetic intermediates
displayed an analogous level of activity, presumably due to their
comparable structures. Notably, the O-methyl or O-benzyl
derivatives 12, 21, and 23 of ningalin A, lamellarin O, and
lukianol A were found to be inactive.
IC50 (µM)a
HCT116/
VP35
(reduced
topo II)
HCT116/
VM46
(MDR)
HCT116
wild type
compound
L1210
ningalin A (1)
lamellarin O (2)
lukianol A (3)
permethyl
80
2
1
1
20
>100
1
15
>100
1
15
>100
>100
storniamide (5)
9
10
11
12
16
17
19
21
23
27
28
30
>100
>100
10
>100
>100
>100
30
50
60
>100
10
90
>100
90
60
>100
>100
>100
>100
>100
>100
80
>100
>100
6
20
7
>100
>100
>100
>100
>100
>100
0.003
0.2
>100
>100
0.2
>100
>100
31
vinblastine
doxorubicin
2.2
0.4
a Quadruplicate assays, average IC50 (variation from mean, (8%).
noncytotoxic concentrations, resensitizing the resistant cell lines
to conventional therapeutic agents.8 P-gp is a 170 kDa plasma
membrane glycoprotein encoded in humans by the gene MDR1
which functions by exporting drugs out of mammalian cells,
lowering their intracellular concentration.27 Therefore, the active
agents and a set of the inactive compounds were also examined
against a wild-type human colon cancer cell line (HTC116) and
two resistant HCT116 cell lines. The first resistant cell line
(HCT116/VM46) embodies the MDR phenotype and overex-
presses P-glycoprotein while the second cell line (HCT116/
VP35) derives its resistance through underexpression of topo-
isomerase II. The examination of the latter cell line along with
the wild-type HCT116 and their comparison with HCT116/
VM46 allow an accurate assessment of the potential MDR
sensitivity as well as an assessment of one potential therapeutic
target. Of the active compounds examined, each proved equally
potent against the three HCT116 cell lines, indicating no MDR
or topo II resistance (Table 1). Most notably, lamellarin O (2)
exhibited a respectable potency against all cell lines examined
and exhibited micromolar activity against the HCT116 cell lines
including the MDR HCT116/VM46, indicating that it, and
related analogues, would not be subject to multidrug resistance
phenotypes derived from overexpression of P-glycoprotein.
More interesting and fundamentally more important, many
of the agents were found to be capable of reversing MDR at
noncytotoxic concentrations, resensitizing HCT116/VM46 to
vinblastine and doxorubicin (Table 2 and Figure 2). Of the
agents examined, 5, 16, 17, and 30 were found to resensitize
HCT116/VM46 to vinblastine or doxorubicin at 1 µM and to
do so more effectively than verapamil. At this concentration,
complete MDR reversal was observed with 5. Thus, the most
effective of the agents capable of reversing MDR was permethyl
storniamide A (5), which exhibited no inherent cytotoxic activity
against the L1210 or HCT116 cell lines and completely reversed
the MDR at a concentration of 1 µM, significantly more potent
than the protoypical agent verapamil. Both 31 and the corre-
sponding primary carboxamide, which represent potential hy-
In addition, a select set of the naturally occurring lamellarins
have been shown to exhibit equally potent cytotoxic activity
against multidrug-resistant (MDR) cell lines arising from
overexpression of P-glycoprotein and/or to reverse MDR at
(23) Hori, M.; Ozeki, H.; Iwamura, T.; Shimizu, H.; Kataoka, T.; Iwata,
N. Heterocycles 1990, 31, 23.
(24) Somanathan, R.; Rivero, I. A.; Aguirre, G.; Ramirez, M. Synth.
Commun. 1996, 26, 1023.
(25) Fre´rot, E.; Coste, J.; Pantaloni, A.; Dufour, M.-N.; Jouin, P.
Tetrahedron 1991, 47, 259.
(26) Attempts at methyl ether cleavage under a variety of conditions
with E,E-5 to provide 4 resulted in only partial methyl ether deprotection
and subsequent decomposition.
(27) Patel, N. H.; Rothenberg, M. L. InVest. New Drugs 1994, 12, 1.
Gottesman, M. M.; Pastan I. Annu. ReV. Biochem. 1993, 62, 385.

58 J. Am. Chem. Soc., Vol. 121, No. 1, 1999
Boger et al.
Table 2. MDR Reversal
gain in
gain in
compound vinblastine sensitivityb doxorubicin sensitivityb
at 1.0 µM IC50 (µM)a (% reversion) IC50 (µM)a (% reversion)
2
3
5
0.1
0.2
2 (3)
1 (0)
67 (100)
250 (370)
2.2 (3)
1.3 (2)
4 (6)
2.0
2.2
0.1
0.08
0.8
2.2
0.3
0.7
1.1 (10)
1 (0)
22 (200)
31 (280)
3 (25)
1 (0)
7 (67)
0.003
0.0008
0.09
0.15
0.05
0.01
0.1
5 (7.5 µM)
9
11
16
17
19
20 (30)
2 (3)
3.1 (28)
21
23
0.1
0.1
2 (3)
2 (3)
27
30
0.2
1 (0)
2.2
0.6
0.08
2.2
2.2
1 (0)
3.6 (40)
31 (280)
1 (0)
0.009
0.0008
0.1
0.2
0.02
22 (33)
250 (370)
2 (3)
1 (0)
10 (15)
30 (7.5 µM)
31
31 (7.5 µM)
verapamil
(1.0 µM)
verapamil
(7.5 µM)
1 (0)
0.003
67 (100)
0.2
11 (100)
a IC50 (µM) of vinblastine or doxorubicin against the MDR resistant
cell line HCT116/VM46 in the presence of 1 µM of the indicated
compound. IC50 values in the absence of added compound are 0.2 µM
(vinblastine) and 2.2 µM (doxorubicin). For the wild-type HCT116 cell
line, not subject to MDR, IC50 values are 0.003 µM (vinblastine) and
0.2 µM (doxorubicin). Average of five experiments, IC50 variability
((8%). b Gain in sensitivity is measured as IC50(-)/IC50(+) [(-) )
without added drug, (+) ) with added drug]: Keller, R. P.; Altermatt,
H. J.; Nooter, K.; Poschmann, G.; Laissue, J. A.; Bollinger, P.; Hiestand,
P. C. Int. J. Cancer 1992, 50, 593.
drolysis products of 5, exhibited no MDR reversal at either 1
or 7.5 µM. At the higher concentrations required for complete
verapamil reversal (7.5 µM), 5 and 30 (7.5 µM) were still more
effective and the HTC116/VM46 cell line became hypersensitive
to vincristine and doxorubicin, exhibiting IC50 values 2-4×
lower than those of the wild type. The concentration dependence
of this reversal was examined more carefully with several of
the agents including the simpler derivative 30, enlisting a
constant and suboptimal concentration of vinblastine (0.01 µg/
mL) in the HCT116/VM46 assay. The results are illustrated in
Figure 2 with 30 which exhibited a well-behaved concentration
dependence for the MDR reversal. Consistent with their action
on P-gp170, both 5 and 30 inhibited dye efflux8 (rhodamine
123) from HT116/VM46 cells (5 > 30), returning the dye
retention to levels equivalent to that of wild type HCT116, and
both had no significant effect on the intracellular dye concentra-
tion in wild type HCT116 cells.
Conclusions. Concise total syntheses of ningalin A (1),
lamellarin O (2), lukianol A (3), and permethyl storniamide A
(5) were completed enlisting a common 1,2,4,5-tetrazine f 1,2-
diazine f pyrrole Diels-Alder strategy featuring the unusually
effective [4 + 2] cycloadditions of the electron-deficient 1,2,4,5-
tetrazine 6 with symmetrical, electron-rich alkynes. The agents
constitute prototypical members of three different classes of
marine natural products characterized by a highly functionalized
tetra- or pentasubstituted pyrrole which is ideally suited to
construction using this strategy. Among these agents, lamellarin
O (2) was found to exhibit micromolar cytotoxic activity against
wild-type and multidrug-resistant tumor cell lines, suggesting
it may serve as a new lead for the development of antitumor
agents insensitive to MDR. Fundamentally more important,
permethyl storniamide A (5) and its synthetic precursor 30,
which lack inherent cytotoxic properties, were shown to potently
reverse MDR, resensitizing a resistant human colon cancer cell
Figure 2. (a) MDR reversal effect of verapamil on the HCT116/VM46
MDR phenotype. The effect of vinblastine on wild-type HCT116 is
also included to illustrate the extent of reversal. (b) MDR reversal effect
of 30 on the HCT116/VM46 MDR phenotype. The effect of vinblastine
on the wild-type HCT116 is also included to illustrate the extent of
reversal. (c) Concentration dependence of MDR reversal by 30 at a
constant suboptimal vinblastine concentration (0.01 µg/mL), against
HCT116/VM46. At these concentrations, 30 alone had no cytotoxic
effect on the cell line (see Table 1).
line (HCT116/VM46) to vinblastine and doxorubicin, and they
constitute the initial members of a new class of MDR reversal
agents.
Experimental Section
1,2-Bis(4,5-dimethoxy-2-(methoxymethoxy)phenyl)acetylene (8).
Nitrogen gas was bubbled through a slurry of 1-bromo-4,5-dimethoxy-
2-(methoxymethoxy)benzene16 (7; 1.67 g, 6.03 mmol, 1.0 equiv) and
Pd(PPh3)4 (0.700 g, 0.60 mmol, 0.1 equiv) in toluene (60 mL) for 15
min. 1,2-Bis(tributylstannyl)acetylene17 (1.9 mL, 3.62 mmol, 0.6 equiv)
was added, and the reaction mixture was warmed to 100 °C for 4 h
under N2. Chromatography (SiO2, 5.5 × 17 cm, 40% EtOAc-hexane)
provided 8 (1.00 g, 79%) as a white crystalline solid: mp 96-97 °C
1
(EtOAc-hexanes); H NMR (CDCl3, 400 MHz) δ 6.95 (s, 2H), 6.71
(s, 2H), 5.23 (s, 4H), 3.87 (s, 6H), 3.84 (s, 6H), 3.54 (s, 6H); 13C NMR
(CDCl3, 100 MHz) δ 152.7, 150.0, 144.2, 114.9, 105.8, 102.0, 96.5,
88.5, 56.4, 56.3, 56.0; IR (film) νmax 2994, 2932, 2820, 1601, 1508,
1452, 1350, 1211, 1150, 1006 cm-1; FABHRMS (NBA/NaI) m/z

Heterocyclic Azadiene Diels-Alder Reactions
J. Am. Chem. Soc., Vol. 121, No. 1, 1999 59
418.1620 (M+, C22H26O8 requires 418.1628). Anal. Calcd for C22H26-
O8: C, 63.15; H, 6.26. Found: C, 62.99; H, 6.05.
EtOAc (5 mL) and washed with saturated aqueous NH4Cl (2 × 10
mL) and saturated aqueous NaCl (10 mL) and dried (Na2SO4) to provide
12 (7.0 mg, 96%, typically 95-100%) as an ivory powder. An
analytically pure sample was prepared by sequential trituration with
Dimethyl 4,5-Bis(4,5-dimethoxy-2-(methoxymethoxy)phenyl)-1,2-
diazine-3,6-dicarboxylate (9). A solution of 8 (0.98 g, 2.3 mmol) and
3,6-dicarbomethoxy-1,2,4,5-tetrazine (6;13 1.39 g, 7.0 mmol, 3.0 equiv)
in toluene (25 mL) was warmed to 105 °C under Ar for 21 h. Additional
6 (0.46 g, 2.3 mmol, 1.0 equiv) was added, and the mixture was further
warmed to 105 °C for 40 h before the reaction mixture was cooled to
25 °C and the solvent was evaporated. Chromatography (SiO2, 3.5 ×
20 cm, 6-8% acetone-CH2Cl2) provided 9 (1.06 g, 87%) as a yellow
crystalline solid: mp 161-162 °C (EtOAc-hexanes); (major atrop-
1
toluene, Et2O, and hexane: mp 328-330 °C; H NMR (DMSO-d6,
500 MHz) δ 14.31 (s, 1H), 7.78 (s, 2H), 7.23 (s, 2H), 3.90 (s, 6H),
3.88 (s, 6H); 13C NMR (DMF-d7, 125 MHz) δ 154.9, 150.7, 146.7,
146.6, 124.5, 122.5, 109.9, 108.8, 102.1, 57.2, 56.2; IR (film) νmax 3231,
2903, 2841, 1711, 1615, 1494, 1228, 830 cm-1; FABHRMS (NBA/
NaI) m/z 423.0976 (M+, C22H17H17NO8 requires 423.0954).
Ningalin A (1). A solution of 12 (6.5 mg, 15.3 µmol) in CH2Cl2
(0.5 mL) at -78 °C was treated with BBr3 (1 M in hexanes, 230 µL,
230 µmol, 15 equiv), and the reaction mixture was allowed to warm to
25 °C over 24 h. Following dilution with CH3OH (500 µL), the solvent
was removed with a stream of N2. Subsequent trituration with toluene
and 10% CH3OH-Et2O afforded pure synthetic 1 (5.4 mg, 96%)
identical in all compared respects (1H NMR, 13C NMR, IR, MS)18 to
naturally derived ningalin A: mp > 260 °C dec; 1H NMR (DMSO-d6,
400 MHz) δ 14.0 (br s, 1H), 9.89 (br s, 2H), 9.44 (br s, 2H), 7.79 (s,
2H), 6.89 (s, 2H); 13C NMR (DMSO-d6, 100 MHz) δ 154.6, 146.4,
144.4, 142.8, 122.9, 122.1, 110.3, 108.4, 104.3; IR (film) νmax 3377,
3179, 1707, 1625, 1497, 1338, 1262, 1164 cm-1; FABHRMS (NBA/
CsI) m/z 499.9364 (M + Cs+, C18H9NO8 requires 499.9382).
1,2-Bis(4-benzyloxyphenyl)acetylene (15). A stirred solution of 1419
(1.70 g, 5.48 mmol, 1.1 equiv), PdCl2(PPh3)2 (0.11 g, 0.15 mmol, 0.03
equiv), and CuI (0.058 g, 0.30 mmol, 0.06 equiv) in Et3N (58 mL)
under N2 at 70 °C was treated with a solution of 1319 (1.04 g, 5.0 mmol)
in Et3N (10 mL) over a period of 1.5 h. The reaction mixture was
allowed to stir for an additional 30 min before it was cooled to 25 °C.
The mixture was diluted with 10% aqueous HCl (50 mL) and was
extracted with CHCl3 (4 × 50 mL), dried (Na2SO4), and concentrated
under reduced pressure. Chromatography (SiO2, 5.5 × 15 cm, 25%
EtOAc-hexane) afforded 15 (1.60 g, 75%) as a white solid. An
analytically pure sample was prepared by recrystallization from toluene
(2×): mp 168-170 °C (lit.30 mp 180-182 °C);1H NMR (CDCl3, 250
MHz) δ 7.44 (d, J ) 8.3 Hz, 4H), 7.37-7.33 (m, 10H), 6.94 (d, J )
8.7 Hz, 4H), 5.08 (s, 4H); FABHRMS (NBA/NaI) m/z 390.1631 (M+,
C28H22O2 requires 390.1620). Anal. Calcd for C28H22O2: C, 86.13; H,
5.68. Found: C, 86.31; H, 5.36.
1
isomer (2.4:1)) H NMR (CDCl3, 400 MHz) δ 6.68 (s, 2H), 6.30 (s,
2H), 5.05 (d, J ) 6.7 Hz, 2H), 4.88 (d, J ) 6.8 Hz, 2H), 3.82 (s, 6H),
3.80 (s, 6H), 3.46 (s, 6H), 3.24 (s, 6H); 13C NMR (CDCl3, 100 MHz)
δ 165.2, 154.8, 150.3, 148.9, 144.1, 137.3, 114.8, 112.5, 100.0, 96.5,
56.0, 55.8, 55.7, 52.9; IR (film) νmax 3006, 2955, 2832, 1739, 1606,
1503, 1431, 1262, 1216, 1149, 1000 cm-1; FABHRMS (NBA/CsI) m/z
721.0982 (M + Cs+, C28H32N2O12 requires 721.1010). Anal. Calcd for
C28H32N2O12: C, 57.14; H, 5.48; N, 4.76. Found: C, 57.00; H, 5.72;
N, 4.86.
Dimethyl 3,4-Bis(4,5-dimethoxy-2-(methoxymethoxy)phenyl)pyr-
role-2,5-dicarboxylate (10). A solution of 9 (30 mg, 0.05 mmol) in
HOAc (650 µL) was treated with Zn dust (33 mg, 0.5 mmol, 10 equiv),
stirred at 25 °C for 4 h, and then treated with an additional 10 equiv
of Zn (33 mg).28 After 12.5 h, the slurry was diluted with EtOAc (10
mL), filtered through Celite, and rinsed with EtOAc (3 × 10 mL). The
filtrate was washed with saturated aqueous NaHCO3 (3 × 10 mL) until
effervescence ceased, washed with saturated aqueous NaCl (20 mL),
dried (Na2SO4), and concentrated in Vacuo. Radial chromatography
(SiO2, 1 mm plate, 6% acetone-CH2Cl2) provided 10 (18.4 mg, 63%)
1
as a white crystalline solid: mp 151-152 °C (EtOAc-hexanes); H
NMR (acetone-d6, 400 MHz) δ 11.10 (br s, 1H), 6.78 (s, 2H), 6.55 (br
s, 2H), 4.88 (br s, 4H), 3.75 (s, 6H), 3.68 (s, 6H), 3.51 (s, 6H), 3.26 (s,
6H); 13C NMR (acetone-d6, 100 MHz) δ 161.4, 150.9, 150.1, 144.7,
128.1, 123.5, 117.1, 116.6, 102.8, 97.2, 56.4, 56.1, 55.8, 51.6; IR (film)
νmax 3272, 3005, 2944, 2831, 1708, 1615, 1492, 1272, 1221, 1149,
995, 759 cm-1; FABHRMS (NBA/CsI) m/z 708.1031 (M + Cs+,
C28H33NO12 requires 708.1057). Anal. Calcd for C28H33NO12: C, 58.43;
H, 5.78; N, 2.43. Found: C, 58.19; H, 5.99; N, 2.34.
Methyl 7,8-Dimethoxy-1-(4,5-dimethoxy-2-hydroxyphenyl)-[1]-
benzopyrano[3,4-b]pyrrol-4(3H)-one-2-carboxylate (11). A sample
of the 10 (18.8 mg, 32.7 µmol) was treated with 3 M HCl-EtOAc
(1.2 mL), and the mixture was stirred at 25 °C for 2 h. Evaporation of
the solvent provided a mixture of dimethyl 3,4-bis(2-hydroxy-4,5-
dimethoxyphenyl)pyrrole-2,5-dicarboxylate and 11.29 Subsequent radial
chromatography (SiO2, 1 mm plate, 8% acetone-CH2Cl2), which also
promoted cyclization of the diphenol, afforded pure 11 (13 mg, 87%,
Dimethyl 3,4-Bis(4-benzyloxyphenyl)-1,2-diazine-2,5-dicarboxy-
late (16). A stirred mixture of 15 (1.00 g, 2.56 mmol) and 613 (0.76 g,
3.84 mmol, 1.5 equiv) in toluene (10 mL) was warmed to 110 °C under
N2 for 48 h. The mixture was cooled to 25 °C, additional 6 (0.76 g,
3.84 mmol, 1.5 equiv) was added, and the mixture was warmed to 110
°C for an additional 24 h. Chromatography (SiO2, 5.5 × 15 cm, 50%
EtOAc-hexane) afforded 16 (1.22 g, 85%) as a yellow solid: mp 169-
171 °C (50% EtOAc-hexane); 1H NMR (CDCl3, 250 MHz) δ 7.41-
7.33 (m, 10H), 6.96 (d, J ) 8.8 Hz, 4H), 6.86 (d, J ) 8.7 Hz, 4H),
5.02 (s, 4H), 3.77 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 165.6, 159.1,
154.8, 138.0, 136.3, 130.5, 128.6, 127.6, 127.5, 124.8, 114.9, 69.9,
52.9; IR (film) νmax 3025, 2953, 2871, 1743, 1605, 1507, 1435, 1374,
1246 cm-1; FABHRMS (NBA/CsI) m/z 693.1020 (M + Cs+, C34H28N2O6
requires 693.1002). Anal. Calcd for C34H28N2O6: C, 72.84; H, 5.03;
N, 5.00. Found: C, 73.13; H, 5.19; N, 4.87.
1
typically 83-94%) as a white powder: mp > 305 °C dec; H NMR
(acetone-d6, 400 MHz) δ 12.09 (br s, 1H), 7.60 (s, 1H), 6.96 (s, 1H),
6.89 (s, 1H), 6.79 (s, 1H), 6.70 (s, 1H), 3.86 (s, 3H), 3.83 (s, 3H), 3.75
(s, 6H), 3.46 (s, 3H); 13C NMR (DMSO-d6, 100 MHz) δ 160.3, 154.2,
149.6, 149.5, 148.8, 145.4, 145.3, 141.6, 128.3, 126.9, 120.6, 117.4,
115.9, 110.5, 109.7, 104.5, 100.8, 100.7, 56.4, 55.9, 55.5, 55.0, 51.7;
IR (film) νmax 3477, 3262, 2954, 2831, 1728, 1707, 1622, 1548, 1494,
1263, 1214, 1150, 1037 cm-1; FABHRMS (NBA/CsI) m/z 588.0287
(M + Cs+, C23H21NO9 requires 588.0271).
Dimethyl 3,4-Bis(4-benzyloxyphenyl)pyrrole-2,5-dicarboxylate
(17). A stirred solution of 16 (0.50 g, 0.89 mmol) in HOAc (10.5 mL)
under N2 at 25 °C was treated with powdered Zn (0.52 g, 8.02 mmol,
9 equiv). After 6 h, additional powdered Zn (0.52 g, 8.02 mmol, 9
equiv) was added, and the reaction was allowed to stir for 12 h. The
mixture was diluted with EtOAc (25 mL), filtered through a pad of
Celite, and rinsed with EtOAc (3 × 20 mL), and the solvent was
removed under reduced pressure. Chromatography (SiO2, 3.8 × 15 cm,
25% EtOAc-hexane) afforded 17 (0.35 g, 72%) as a white solid: mp
Tetramethyl Ningalin A (12). A solution of 11 (8.0 mg, 17.6 µmol)
in toluene (1.8 mL) was treated with DBU (8.0 µL, 53.4 µmol, 5.0
equiv) and stirred at 105 °C for 12 h. The solution was diluted with
(28) The initial product, the corresponding 1,4-dihydro-1,2-diazine, could
be isolated at intermediate stages of the reaction (10-20%) and character-
ized: 1H NMR (CDCl3, 400 MHz) major atropisomer, δ 7.05 (br s, 1H),
6.66 (s, 1H), 6.61 (s, 2H), 6.47 (s, 1H), 5.07 (d, J ) 7.0 Hz, 1H), 4.95 (d,
J ) 6.5 Hz, 1H), 4.90 (s, 2H), 4.62 (s, 1H), 3.81 (s, 3H), 3.80 (s, 3H), 3.79
(s, 3H), 3.66 (s, 3H), 3.50 (s, 3H), 3.47 (s, 3H), 3.42 (s, 3H), 3.39 (s, 3H);
FABHRMS (NBA/CsI) m/z 723.1191 (M + Cs+, C28H34N2O12 requires
723.1166).
(29) The ratio of diphenol to monolactone 11 ranged from 1.2:1 to 1:7,
and the amount of 11 increased with time. The diphenol was never isolated,
but in the mixture it exhibited the following 1H NMR (acetone-d6, 400
MHz): δ 11.24 (br s, 1H), 7.18 (br s, 2H), 6.51 (s, 2H), 6.42 (s, 2H), 3.71
(s, 6H), 3.69 (s, 6H), 3.51 (s, 6H).
1
164-165 °C (25% EtOAc-hexane); H NMR (CDCl3, 250 MHz) δ
9.78 (br s, 1H), 7.45-7.16 (m, 10H), 7.05 (d, J ) 8.7 Hz, 4H), 6.84
(d, J ) 8.7 Hz, 4H), 5.02 (s, 4H), 3.78 (s, 6H); 13C NMR (CDCl3, 100
MHz) δ 160.7, 157.8, 136.9, 131.9, 131.2, 128.5, 127.9, 127.6, 125.3,
121.1, 113.8, 69.9, 51.7; IR (film) νmax 3438, 3287, 3032, 2950, 1701,
1465, 1298, 1243 cm-1; FABHRMS (NBA/CsI) m/z 680.1032 (M +
(30) Broser, W.; Brockt, M. Tetrahedron Lett. 1967, 3117.

60 J. Am. Chem. Soc., Vol. 121, No. 1, 1999
Boger et al.
Cs+, C34H29NO6 requires 680.1049). Anal. Calcd for C34H29NO6: C,
74.57; H, 5.34; N, 2.56. Found: C, 74.70; H, 5.42; N, 2.47.
3H), 3.40 (s, 3H); 13C NMR (acetone-d6, 125 MHz) δ 192.7, 164.9,
162.9, 157.0, 156.6, 132.7, 131.5, 131.1, 130.2, 129.3, 128.3, 128.1,
127.2, 125.2, 120.7, 115.84, 115.80, 115.23, 115.20, 114.9, 56.5, 56.1,
50.7; IR (film) νmax 3430, 2912, 1682, 1600, 1436, 1241, 1169, 1097,
1025 cm-1; FABHRMS (NBA/CsI) m/z 590.0601 (M + Cs+, C27H23-
NO6 requires 590.0580).
Dimethyl 3,4-Bis(4-benzyloxyphenyl)-1-[2-(4-methoxyphenyl)-2-
oxoethyl]pyrrole-2,5-dicarboxylate (19). A stirred mixture of 17 (0.30
g, 0.55 mmol), 18 (0.138 g, 0.60 mmol, 1.1 equiv), and K2CO3 (0.227
g, 1.64 mmol, 3 equiv) in DMF (2.2 mL) under N2 was warmed to 70
°C for 1 h. The mixture was cooled to 25 °C, diluted with H2O (10
mL), extracted with EtOAc (3 × 5 mL), dried (Na2SO4), and
concentrated under reduced pressure. Chromatography (SiO2, 3.8 ×
15 cm, 40% EtOAc-hexane) afforded 19 (0.38 g, 100%) as a white
solid: mp: 166.5-167.5 °C (40% EtOAc-hexane); 1H NMR (CDCl3,
250 MHz) δ 8.05 (d, J ) 8.8 Hz, 2H), 7.45-7.16 (m, 10H), 7.00 (d,
J ) 9.0 Hz, 2H), 6.99 (d, J ) 8.7 Hz, 4H), 6.80 (d, J ) 8.6 Hz, 4H),
6.38 (s, 2H), 5.01 (s, 4H), 3.90 (s, 3H), 3.49 (s, 6H); 13C NMR (CDCl3,
100 MHz) δ 192.1, 163.9, 162.2, 157.4, 137.0, 131.7, 131.6, 131.5,
130.3, 128.5, 128.0, 127.9, 127.6, 127.1, 124.3, 114.0, 113.6, 69.8,
55.5, 53.1, 51.3; IR (film) νmax 3034, 2950, 2910, 2848, 1712, 1601,
1532, 1437, 1299, 1237 cm-1; FABHRMS (NBA/CsI) m/z 828.1594
(M + Cs+, C43H37NO8 requires 828.1574). Anal. Calcd for C43H37-
NO8: C, 74.23; H, 5.36; N, 2.01. Found: C, 73.87; H, 5.65; N, 1.99.
3,4-Bis(4-benzyloxyphenyl)-5-(methoxycarbonyl)-1-[2-(4-methox-
yphenyl)-2-oxoethyl]pyrrole-2-carboxylic Acid (20). A stirred solution
of 19 (0.30 g, 0.43 mmol) and LiOH (0.013 g, 0.56 mmol, 1.3 equiv)
in 3:2:1 THF-CH3OH-H2O (8.6 mL) was warmed to 50 °C for 6 h.
The reaction mixture was diluted with 10% aqueous KOH (5 mL) and
was extracted with EtOAc (5 mL). The aqueous phase was acidified
with 10% aqueous HCl (pH 1) and was extracted with CH2Cl2 (3 × 5
mL) and dried (Na2SO4), and the solvent was removed under reduced
pressure. Chromatography (SiO2, 3.8 × 15 cm, 5% CH3OH-CH2Cl2)
afforded pure 20 (0.22 g, 76%): mp 190-191 °C (i-PrOH); 1H NMR
(CDCl3, 250 MHz) δ 8.02 (d, J ) 8.8 Hz, 2H), 7.44-7.32 (m, 10H),
7.06 (d, J ) 8.6 Hz, 2H), 6.98 (d, J ) 8.8 Hz, 2H), 6.97 (d, J ) 8.6
Hz, 2H), 6.81 (t, J ) 9.1 Hz, 4H), 6.39 (s, 2H), 5.00 (s, 2H), 4.99 (s,
2H), 3.87 (s, 3H), 3.49 (s, 3H); 13C NMR (CDCl3, 100 MHz) 192.2,
163.8, 162.1, 157.7, 157.4, 137.0, 136.9, 131.9, 131.6, 130.3, 128.5,
128.0, 127.9, 127.7, 127.6, 114.0, 113.8, 113.6, 69.8, 55.5, 53.2, 51.4;
IR (film) νmax 3351-2800, 3031, 2916, 2848, 1708, 1600, 1531, 1435,
1239 cm-1; FABHRMS (NBA/CsI) m/z 814.384 (M + Cs+, C42H35-
NO8 requires 814.1417). Anal. Calcd for C42H35NO8: C, 74.00; H, 5.17;
N, 2.05. Found: C, 73.74; H, 5.53; N, 2.23.
Method B. A sample of crude 21 (7 mg, 0.011 mmol) was warmed
in neat trifluoroacetic acid (0.56 mL) at 70 °C for 3 h. The mixture
was cooled to 25 °C, and the solvent was diluted with saturated aqueous
NaHCO3 (5 mL), extracted with CH2Cl2 (3 × 2 mL), dried (Na2SO4),
and concentrated under reduced pressure. Chromatography (SiO2, 1.9
× 15 cm, 35% EtOAc-hexane) afforded 2 (4.2 mg, 84%) as a white
solid identical in all respects to the material described above.
1H-7,8-Bis(4-benzyloxyphenyl)-3-(methoxyphenyl)pyrrolo[2,1-c]-
[1,4]-oxazin-1-one (23). A stirred solution of 21 (0.025 g, 0.039 mmol)
and LiOH (0.0028 g, 0.067 mmol, 1.7 equiv) in 3:2:1 THF-CH3OH-
H2O (0.4 mL) was warmed to 50 °C for 6 h. The reaction mixture was
diluted with 10% aqueous KOH (5 mL) and was extracted with EtOAc
(5 mL). The aqueous phase was acidified with 10% aqueous HCl (pH
1), extracted with CH2Cl2 (3 × 3 mL), and dried (Na2SO4), and the
solvent was removed under reduced pressure to afford 22 (0.023 g,
98%). The compound was used without further purification.
A stirred solution of 22 (0.023 g) and NaOAc (0.055 g, 0.67 mmol,
18.1 equiv) in Ac2O (3.0 mL) was warmed to 100 °C for 1 h. The
mixture was cooled to 25 °C, and the solvent was removed by
coevaporation with toluene. The residue was diluted with Et2O (10 mL),
washed with saturated aqueous NaHCO3 (3 × 3 mL), dried (Na2SO4),
and concentrated under reduced pressure. Chromatography (SiO2, 1.9
× 15 cm, 50% EtOAc-hexane) afforded 23 (0.017 g, 72%) as a white
1
solid: mp 184-185 °C (Et2O); H NMR (CDCl3, 250 MHz) δ 7.62
(d, J ) 8.8 Hz, 2H), 7.48-7.28 (m, 15H), 7.22 (s, 1H), 6.97 (d, J )
8.8 Hz, 2H), 6.96 (d, J ) 8.8 Hz, 2H), 6.88 (d, J ) 8.8 Hz, 2H), 5.08
(s, 2H), 5.04 (s, 2H), 3.86 (s, 3H);13C NMR (CDCl3, 100 MHz) δ 160.5,
158.3, 157.8, 154.3, 142.0, 137.0, 136.9, 132.1, 129.8, 129.7, 128.6,
128.5, 128.1, 128.00, 127.96, 127.7, 127.5, 126.1, 125.8, 124.9, 123.1,
118.9, 114.8, 114.3, 114.2, 114.1, 112.9, 102.7, 70.0, 55.3; IR (film)
νmax 3108, 3033, 2938, 1732, 1608, 1515, 1428, 1245, 1176 cm-1
;
FABHRMS (NBA/CsI) m/z 738.1279 (M + Cs+, C40H31NO5 requires
738.1257). Anal. Calcd for C40H31NO5: C, 79.32; H, 5.16; N, 2.31.
Found C, 78.97; H, 4.83; N, 2.34.
Methyl 3,4-Bis(4-benzyloxyphenyl)-1-[2-(4-methoxyphenyl)-2-
oxoethyl]pyrrole-2-carboxylate (21). A stirred solution of 20 (0.10
g, 0.147 mmol) in CH2Cl2 (1.5 mL) under N2 was treated with
trifluoroacetic acid (0.056 mL, 0.733 mmol, 5 equiv), and the solution
was warmed to 40 °C for 5 h. The mixture was cooled to 25 °C, and
the solvent was diluted with saturated aqueous NaHCO3 (5 mL),
extracted with CH2Cl2 (3 × 2 mL), dried (Na2SO4), and concentrated
under reduced pressure. Chromatography (SiO2, 1.9 × 15 cm, 35%
EtOAc-hexane) afforded 21 (0.091 g, 97%) as a white solid: mp 120-
Lukianol A (3). A stirred solution of 23 (10 mg, 0.0165 mmol) in
CH2Cl2 (0.33 mL) at -78 °C was treated with BBr3 (0.148 mL as a 1
M solution in hexanes, 9 equiv) dropwise over a 20 min period. The
solution was stirred at -78 °C for 1 h and gradually warmed to 25 °C.
The solution was diluted with Et2O (25 mL) and EtOAc (5 mL) and
washed with H2O (2 × 5 mL) and saturated aqueous sodium chloride
(5 mL). Chromatography (SiO2, 1.9 × 15 cm, 33% EtOAc-hexane)
afforded 3 (4.9 mg, 72%) as a white solid identical in all compared
respects (1H NMR, 13C NMR, mp)31 with authentic material: mp 264-
1
1
266 °C (lit.15 mp 264-266 °C); H NMR (DMSO-d6, 250 MHz) δ
121 °C (Et2O); H NMR (CDCl3, 250 MHz) δ 8.04 (d, J ) 8.8 Hz,
2H), 7.49-7.34 (m, 10H), 7.18 (d, J ) 8.6 Hz, 2H), 7.04-6.99 (m,
4H), 6.93 (s, 1H), 6.92 (d, J ) 8.4 Hz, 2H), 6.81 (d, J ) 8.6 Hz, 2H),
5.74 (s, 2H), 5.08 (s, 2H), 5.00 (s, 2H), 3.90 (s, 3H) 3.47 (s, 3H);13C
NMR (CDCl3, 100 MHz) δ 191.8, 164.0, 162.3, 157.5, 157.1, 137.1,
137.0, 131.9, 131.0, 130.3, 129.4, 128.5, 128.2, 127.9, 127.6, 127.5,
127.2, 124.6, 119.7, 114.4, 114.1, 113.8, 88.4, 69.9, 55.5, 50.8; IR (film)
9.88 (br s, 1H), 9.46 (br s, 1H), 9.42 (br s, 1H), 8.05 (br s, 1H), 7.60
(s, 1H), 7.56 (d, J ) 8.7 Hz, 2H), 7.05 (d, J ) 8.4 Hz, 2H), 6.95 (d,
J ) 8.6 Hz, 2H), 6.88 (d, J ) 8.6 Hz, 2H), 6.70 (d, J ) 8.6 Hz, 2H),
6.66 (d, J ) 8.6 Hz, 2H);13C NMR (DMSO-d6, 100 MHz) δ 158.4,
156.6, 156.3, 153.6, 140.8, 131.8, 129.4, 128.7, 127.3, 125.5, 123.9,
123.1, 121.3, 120.0, 115.8, 115.2, 114.6, 111.9, 103.1; IR (film) νmax
3406, 1653, 1613, 1420, 1269, 1025, 997 cm-1; FABHRMS (NBA/
NaI) m/z 412.1201 (M + H+, C25H17NO5 requires 412.1185).
1,2-Bis(3,4,5-trimethoxyphenyl)acetylene (26). A stirred solution
of 2521 (0.50 g, 1.58 mmol), PdCl2(PPh3)2 (0.11 g, 0.16 mmol, 0.1
equiv), CuI (0.09 g, 0.47 mmol, 0.3 equiv), and Bu4NI (1.75 g, 4.74
mmol, 3.0 equiv) in 5:1 DMF-Et3N (8.0 mL) under Ar at 70 °C was
treated with 2421 (0.43 g, 2.21 mmol, 1.4 equiv) in 5:1 DMF-Et3N
(4.0 mL) over a period of 1.5 h. The reaction mixture was allowed to
stir for an additional 30 min before it was cooled to 25 °C, diluted
with 10% aqueous HCl (50 mL), and extracted with CHCl3 (4 × 50
mL). The combined organic extracts were dried (Na2SO4) and
concentrated under reduced pressure. Chromatography (SiO2, 5.5 ×
15 cm, CHCl3) afforded 26 (0.51 g, 90%) as a yellow-brown solid. An
analytically pure sample could be prepared by recrystallizaton from
toluene: mp 192-195 °C; 1H NMR (CDCl3, 250 MHz) δ 6.77 (s, 4H),
ν
max 3032, 2948, 1691, 1600, 1532, 1441, 1237, 1171 cm-1; FABHRMS
(NBA/CsI) m/z 770.1539 (M + Cs+, C41H35NO6 requires 770.1519).
Lamellarin O (2). Method A. A solution of 21 (10.4 mg, 0.0163
mmol) and Pd/C (1 mg, 0.1 wt equiv) in EtOH (0.16 mL) under H2
was stirred at 25 °C for 1 h. The solution was filtered through a pad of
Celite, and the solvent was removed under reduced pressure to afford
2 (7.5 mg, 100%) as a white solid identical in all compared results (1H
NMR, 13C NMR, IR, mp)31 to authentic material: mp 259-261 °C
1
(lit.15 mp 259-260 °C; unstable pale yellow oil2); H NMR (acetone-
d6, 400 MHz) δ 8.08 (d, J ) 8.6 Hz, 2H), 7.18 (s, 1H), 7.11 (d, J )
8.6 Hz, 2H), 7.02 (d, J ) 8.4 Hz, 2H), 6.93 (d, J ) 8.4 Hz, 2H), 6.76
(d, J ) 8.6 Hz, 2H), 6.64 (d, J ) 8.6 Hz, 2H), 5.91 (s, 2H), 3.93 (s,
(31) We thank Professors Capon and Scheuer for providing copies of
the original spectra of lamellarin O and lukianol A, respectively, for direct
comparison.

Heterocyclic Azadiene Diels-Alder Reactions
J. Am. Chem. Soc., Vol. 121, No. 1, 1999 61
3.89 (s, 12H), 3.88 (s, 6H); 13C NMR (CDCl3, 62.5 MHz) δ 153.0,
139.0, 118.0, 108.6, 88.4, 60.9, 56.0; IR (film) νmax 2941, 1574, 1508,
1410, 1236, 1128 cm-1; FABHRMS (NBA/NaI) m/z 358.1406 (M+,
C20H22O6 requires 358.1416). Anal. Calcd for C20H22O6: C, 67.03; H,
6.19. Found: C, 67.34; H, 6.36.
3,4-Bis(3,4,5-trimethoxyphenyl)-1-[2-(4-methoxyphenyl)ethyl]-
pyrrole-2,5-bis[N-(2-(4-methoxyphenyl)-2-phenylthio)ethyl]carbox-
amide (33). A stirred solution of 31 (5.5 mg, 8.8 µmol), 2-(4-
methoxyphenyl)-2-(phenylthio)-1-aminoethane (32;24 4.6 mg, 18 µmol,
2.05 equiv), and i-Pr2NEt (8.0 µL, 40 µmol, 5.0 equiv) under Ar at 25
°C was treated with PyBrOP25 (8.8 mg, 19 µmol, 2.1 equiv), and the
reaction was stirred for 2 h. Chromatography (SiO2, 1.5 × 12 cm, 10%
EtOAc-hexane) afforded 33 (9.9 mg, 100%) as a light yellow foam:
1H NMR (CDCl3, 400 MHz) δ 7.21-7.12 (m, 12H), 6.87 (d, J ) 6.8
Hz, 4H), 6.82 (d, J ) 6.8 Hz, 2H), 6.69 (d, J ) 6.8 Hz), 6.21 (s, 4H),
5.69 (t, J ) 4.0 Hz, 2H), 3.96 (dt, J ) 6.1, 2.4 Hz, 2H), 3.80 (s, 6H),
3.77 (s, 3H), 3.74-3.67 (m, 2H), 3.72 (s, 6H), 3.61 (s, 12H), 3.56-
3.46 (m, 2H), 3.04 (t, J ) 4.0 Hz, 2H); 13C NMR (CDCl3, 100 MHz)
δ 161.5, 158.9, 158.2, 153.1, 137.1, 133.0, 132.8, 130.8, 130.4, 130.3,
128.9, 128.8, 128.6, 127.6, 126.2, 124.8, 113.9, 113.7, 107.3, 60.8,
56.0, 55.2, 55.1, 51.5, 48.4, 43.5, 37.6, 29.7; FABHRMS (NBA) m/z
1104.4195 (M + H+, C63H65N3O11S2 requires 1104.4138).
E,E-3,4-Bis(3,4,5-trimethoxyphenyl)-1-[2-(4-methoxyphenyl)eth-
yl]pyrrole-2,5-bis[N-2-(4-methoxystyryl)]carboxamide (Permethyl
Storniamide A, 5). A stirred solution of 33 (14.5 mg, 13.0 µmol) in
CH3OH (0.2 mL) under Ar at 25 °C was treated with NaIO4 (56 mg,
0.26 mmol, 20.0 equiv) in H2O (0.1 mL). The mixture was stirred for
6 h at 25 °C, diluted with H2O (5 mL), and extracted with 5% CH3-
OH-CHCl3 (4 × 5 mL) to afford the disulfoxide as a light yellow
solid which was used without further purification. The resulting solid
and Na2CO3 (3.5 mg, 33 µmol, 5.0 equiv) were diluted with toluene
(0.26 mL) and were warmed to 80 °C (18 h) and 110 °C (12 h). PTLC
(SiO2, 0.25 mm × 20 cm × 20 cm, 50% EtOAc-hexane, two elutions)
afforded a 2:1 mixture of the desired E,E-isomer 5 (5.8 mg, 50%) and
the E,Z-isomer (3.0 mg, 26%). Data for E,E-5: 1H NMR (CDCl3, 400
MHz) δ 7.37 (dd, J ) 14.6, 10.8 Hz, 2H), 7.16 (d, J ) 8.1 Hz, 4H),
7.13 (d, J ) 8.4 Hz, 2H), 7.00 (d, J ) 10.5 Hz, 2H), 6.81 (d, J ) 8.1
Hz, 4H), 6.74 (d, J ) 8.4 Hz, 2H), 6.37 (s, 4H), 5.45 (d, J ) 14.3 Hz,
2H), 5.01 (t, J ) 7.0 Hz, 2H), 3.85 (s, 6H), 3.79 (s, 6H), 3.68 (s, 15H),
3.15 (t, J ) 7.0 Hz, 2H);32 13C NMR (CDCl3, 62.5 MHz) δ 162.0,
158.7, 158.3, 157.9, 153.4, 137.8, 130.4, 128.3, 128.2, 126.6, 126.3,
126.0, 120.2, 114.2, 113.7, 113.0, 107.8, 61.0, 56.3, 55.3, 55.1, 48.6,
37.5; IR (film) νmax 3374, 2936, 2834, 1667, 1650, 1607, 1580, 1511,
1504, 1245, 1177, 1126, 1032, 944, 845 cm-1; FABHRMS (NBA/NaI)
m/z 906.3607 (M + Na+, C51H53N3O11 requires 906.3578). Data for
E,Z-5: 1H NMR (CDCl3, 400 MHz) δ 7.53 (d, J ) 11.3 Hz, 1H), 7.37
(dd, J ) 14.6, 11.1 Hz, 1H), 7.15 (d, J ) 8.6 Hz, 4H), 7.05 (d, J )
11.1 Hz, 1H), 6.93 (dd, J ) 11.3, 9.4 Hz, 1H), 6.80 (d, J ) 8.6 Hz,
2H), 6.76 (d, J ) 8.6 Hz, 2H), 6.63 (d, J ) 8.6 Hz, 2H), 6.41 (d, J )
8.6 Hz, 2H), 6.32 (s, 2H), 6.30 (s, 2H), 5.62 (d, J ) 9.5 Hz, 1H), 5.43
(d, J ) 14.6 Hz, 1H), 4.93 (t, J ) 7.0 Hz, 2H), 3.85 (s, 3H), 3.79 (s,
3H), 3.75 (s, 3H), 3.72 (s, 3H), 3.67 (s, 6H), 3.64 (s, 9H), 3.14 (t, J )
7.0 Hz, 2H); FABHRMS (NBA/CsI) m/z 1016.2777 (M + Cs+,
C51H53N3O11 requires 1016.2734). A trace amount of the Z,Z-isomer
was also isolated, accumulated, and characterized: 1H NMR (CDCl3,
400 MHz) δ 7.56 (d, J ) 11.3 Hz, 2H), 7.17 (d, J ) 8.6 Hz, 2H), 6.92
(dd, J ) 11.3, 9.4 Hz, 2H), 6.75 (d, J ) 8.4 Hz, 2H), 6.62 (d, J ) 8.6
Hz, 4H), 6.41 (d, J ) 8.6 Hz, 4H), 6.23 (s, 4H), 5.61 (d, J ) 9.4 Hz,
2H), 4.84 (t, J ) 7 Hz, 2H), 3.74 (s, 6H), 3.72 (s, 3H), 3.62 (s, 12H),
3.12 (t, J ) 7 Hz, 2H); FABHRMS (NBA/CsI) m/z 1016.2779 (M +
Cs+, C51H53N3O11 requires 1016.2734).
Dimethyl 4,5-Bis(3,4,5-trimethoxyphenyl)-1,2-diazine-3,6-dicar-
boxylate (27). A stirred mixture of 26 (25.0 mg, 69.0 µmol) and 613
(20.5 mg, 104 µmol, 1.5 equiv) in toluene (0.14 mL) was warmed to
110 °C under Ar for 24 h and was cooled to 25 °C, and additional 6
(20.5 mg, 104 µmol, 1.5 equiv) was added to the reaction. The mixture
was warmed at 110 °C for an additional 24 h and was allowed to cool
to 25 °C. Chromatography (SiO2, 1.0 × 14 cm, 50% EtOAc-hexane)
afforded 27 (23.4 mg, 90%) as a light orange solid: mp 143-144 °C
1
(50% EtOAc-hexane); H NMR (CDCl3, 250 MHz) δ 6.28 (s, 4H),
3.83 (s, 12H), 3.64 (s, 12H); 13C NMR (CDCl3, 62.5 MHz) δ 165.6,
154.5, 153.2, 138.6, 137.5, 127.5, 106.6, 61.0, 56.1, 53.2; IR (film)
νmax 2918, 1741, 1584, 1411, 1239, 1125 cm-1; FABHRMS (NBA/
CsI) m/z 661.0824 (M + Cs+, C26H28N2O10 requires 661.0798). Anal.
Calcd for C26H28N2O10: C, 59.09; H, 5.34; N, 5.30. Found: C, 58.94;
H, 5.10; N, 5.09.
Dimethyl 3,4-Bis(3,4,5-trimethoxyphenyl)pyrrole-2,5-dicarboxy-
late (28). A stirred solution of 27 (29.0 mg, 54.9 µmol) in HOAc (0.7
mL) under Ar at 25 °C was treated with powdered Zn (32 mg, 49.5
mmol, 9.0 equiv). After 6 h, additional powdered Zn (32 mg, 49.5
mmol, 9.0 equiv) was added, and the reaction mixture was allowed to
stir for 12 h. The mixture was diluted with 5% CH3OH-CHCl3 (5
mL) and filtered through a pad of Celite which was rinsed with 5%
CH3OH-CHCl3 (50 mL), and the solvent was removed under reduced
pressure. Chromatography (SiO2, 5.5 × 15 cm, 4% acetone-CH2Cl2)
afforded 28 (19.6 mg, 69%) as a light yellow solid: mp 153-155 °C
(4% acetone-CH2Cl2); 1H NMR (CDCl3, 250 MHz) δ 9.86 (br s, 1H),
6.37 (s, 4H), 3.82 (s, 12H), 3.64 (s, 12H); 13C NMR (CDCl3, 62.5 MHz)
δ 160.6 (2C), 152.3 (4C), 137.1 (2C), 131.1 (2C), 128.1 (2C), 121.0
(2C), 108.3 (4C), 60.9 (2C), 56.0 (4C), 51.9 (2C); IR (film) νmax 3270,
2938, 1710, 1586, 1465, 1340, 1240, 1125 cm-1; FABHRMS (NBA/
CsI) m/z 648.0859 (M + Cs+, C26H29NO10 requires 648.0896). Anal.
Calcd for C26H29NO10: C, 60.58; H, 5.67; N, 2.72. Found: C, 60.94;
H, 5.63; N, 2.66.
Dimethyl 3,4-Bis(3,4,5-trimethoxyphenyl)-1-[2-(4-methoxyphen-
yl)ethyl]pyrrole-2,5-dicarboxylate (30). A stirred mixture of 28 (0.21
g, 0.41 mmol), 4-methoxyphenethyl bromide (29;23 0.44 g, 2.03 mmol,
5.0 equiv), and K2CO3 (0.28 g, 2.03 mmol, 5.0 equiv) in DMF (4.1
mL) under Ar was warmed to 110 °C for 1.5 h. The mixture was cooled
to 25 °C, and the solvent was removed under reduced pressure.
Chromatography (SiO2, 2.5 × 15 cm, 2% acetone-CH2Cl2) afforded
30 (0.26 g, 100%) as a light yellow solid: mp 118-119 °C (2%
acetone-CH2Cl2); 1H NMR (CDCl3, 250 MHz) δ 7.22 (d, J ) 8.5 Hz,
2H), 6.87 (d, J ) 8.5 Hz, 2H), 6.24 (s, 4H), 4.81 (t, J ) 7.4 Hz, 2H),
3.81 (s, 6H), 3.80 (s, 3H), 3.66 (s, 6H), 3.65 (s, 12H), 3.12 (t, J ) 7.6
Hz, 2H); 13C NMR (CDCl3, 62.5 MHz) δ 162.0, 158.3, 152.2, 136.7,
130.3, 130.0, 129.8, 123.8, 113.9, 107.8, 60.9, 56.0, 55.2, 51.6, 48.9,
37.4; IR (film) νmax 2934, 1719, 1584, 1512, 1410, 1237, 1127 cm-1
.
Anal. Calcd for C35H39NO11: C, 64.70; H, 6.05; N, 2.16. Found: C,
64.39; H, 6.41; N, 2.37.
3,4-Bis(3,4,5-trimethoxyphenyl)-1-[2-(4-methoxyphenyl)ethyl]-
pyrrole-2,5-dicarboxylic Acid (31). A stirred solution of 30 (0.13 g,
0.20 mmol) and KOH (0.11 g, 2.00 mmol, 5.0 equiv) in 4:2:1 dioxane-
CH3OH-H2O (1.0 mL) was warmed to 70 °C for 72 h. The reaction
mixture was diluted with 10% aqueous KOH (5 mL) and was extracted
with EtOAc (5 mL). The aqueous phase was acidified with concentrated
HCl (pH 1), extracted with 5% CH3OH-CHCl3 (20 mL), and dried
(Na2SO4), and the solvent was removed under reduced pressure to afford
Determination of Cytotoxicity and the Effect on MDR Reversals.
The L1210 cytotoxic assays were performed as previously described.33
Human colon carcinoma cells HCT116, HCT116/VM46 (MDR, over-
expression of P-glycoprotein), and HCT116/VP35 (with reduced levels
of topoisomerase II)34 were obtained from Drs. D. M. Floyd and C. R.
Fairchild of Bristol-Myers Squibb and were cultured in RPMI 1640
media supplemented with 10% FBS. Upon performing the assay, 3000
cells in 100 µL medium were seeded into each well of 96-well cluster
1
pure 31 (0.13 g, 100%): mp 182-185 °C (Et2O); H NMR (CDCl3,
400 MHz) δ 7.13 (d, J ) 8.5 Hz, 2H), 6.28 (d, J ) 8.5 Hz, 2H), 6.31
(s, 4H), 4.92 (t, J ) 7.4 Hz, 2H), 3.81 (s, 6H), 3.77 (s, 3H), 3.65 (s,
12H), 3.12 (t, J ) 7.6 Hz, 2H); 13C NMR (CDCl3, 62.5 MHz) δ 165.4,
158.5, 152.3, 137.1, 132.7, 129.9, 129.8, 129.0, 123.6, 114.0, 108.2,
60.8, 56.0, 55.2, 49.4, 37.2; IR (film) νmax 3189, 2935, 1712, 1585,
1513, 1425, 1240, 1127 cm-1; FABHRMS (NBA/CsI) m/z 661.0824
(M + Cs+, C33H35NO11 requires 661.0798). Anal. Calcd for C33H35-
NO11: C, 63.76; H, 5.68; N, 2.25. Found: C, 63.90; H, 5.70; N, 2.35.
(32) The 1H NMR of E,E-5 (CDCl3, 400 MHz) was in excellent
agreement with that reported for 49 (acetone-d6-CD3OD, 9:1), and only
the â enamide proton exhibited a significantly altered chemical shift of δ
5.45 (d, J ) 14.3 Hz) versus δ 5.74 (d, J ) 14 Hz).9
(33) Boger, D. L.; Chai, W.; Jin, Q. J. Am. Chem. Soc. 1998, 120, 7220.
(34) Long, H. B.; Wang, L.; Lorico, A.; Wang, R. C. C.; Brattain, M.
G.; Casazza, A. M. Cancer Res. 1991, 51, 5275.

62 J. Am. Chem. Soc., Vol. 121, No. 1, 1999
Boger et al.
dishes, and cell incubation was allowed to proceed for 24 h. Then 98
µL of the medium was added to each well. The antitumor drugs
(vinblastine or doxorubicin), verapamil, and our synthetic compounds
were dissolved in DMSO and were prepared in serial dilutions. A 1
µL sample of the synthetic compound solution and a 1 µL sample of
the antitumor drug solution were added sequentially to the same well
for MDR reversal studies, or 2 µL of the synthetic compound solution
was added to a well for cytotoxicity studies. The components in the
well were mixed by drawing the liquid up and down four times using
a pipet. The culture was incubated for another 72 h. At the end of the
incubation, the medium was removed and 100 µL of 10 mM acid
phosphatase substrate, p-nitrophenyl phosphate (Sigma), in 0.1 M
sodium acetate (pH 5.5), 0.1% Triton X-100, was added to each well.
This incubation was allowed to proceed for 10 h, before 50 µL of 1 N
sodium hydroxide was added for colorimetric absorbance determina-
tion35 (Emax, Molecular Devices). The wells in the first row of a culture
plate contained cultural medium only and were used as blanks. Wells
containing cells treated only with DMSO (1%) were used as controls.
Acknowledgment. We gratefully acknowledge the financial
support of the National Institutes of Health (Grant CA42056),
the Skaggs Institute for Chemical Biology, the award of an ACS
Medicinal Division fellowship sponsored by Bristol-Myers
Squibb (1998-1999, C.W.B.), and a National Institutes of
Health postdoctoral fellowship (F32 GM19021, C.A.S.). We are
especially grateful to D. M. Floyd and C. R. Fairchild of Bristol-
Myers Squibb for providing the HCT116, HCT116/VM46, and
HCT116/VP35 cell lines enlisted herein.
JA982078+
(35) Connolly, D. T.; Knight, M. B.; Harakas, N. K.; Wittwer, A. J.;
Peder, J. Anal. Biochem. 1986, 152, 136.